TG Therapeutics (TGTX) Misses Q1 EPS by 6c

TG Therapeutics (NASDAQ: TGTX) reported Q1 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $40 thousand.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Stellantis stock slips as JPMorgan downgrades on delayed payoff from cost cuts
• Citi upgrades Knight-Swift and Saia to Buy after trucking stock pullback